Safety and Immunogenicity of the Candidate Tuberculosis Vaccine MVA85A in West Africa

BACKGROUND: Vaccination with a recombinant modified vaccinia Ankara expressing antigen 85A from Mycobacterium tuberculosis, MVA85A, induces high levels of cellular immune responses in UK volunteers. We assessed the safety and immunogenicity of this new vaccine in West African volunteers. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Brookes, Roger H., Hill, Philip C., Owiafe, Patrick K., Ibanga, Hannah B., Jeffries, David J., Donkor, Simon A., Fletcher, Helen A., Hammond, Abdulrahman S., Lienhardt, Christian, Adegbola, Richard A., McShane, Helen, Hill, Adrian V. S.
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2008
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2488375/
https://www.ncbi.nlm.nih.gov/pubmed/18698342
http://dx.doi.org/10.1371/journal.pone.0002921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2488375/
https://www.ncbi.nlm.nih.gov/pubmed/18698342
http://dx.doi.org/10.1371/journal.pone.0002921

Ejemplares similares